OCGN Ocugen, Inc. Insider Trading

CFO Treerita Essalima Johnson-Greene buys 21,000 shares at $1.23; stock down 54.8% from 52-week high and 45.1% over 90 days.

On 2026-06-15, Ocugen's Chief Financial Officer purchased 21,000 shares at $1.23, increasing her holdings from 500,000 shares to 521,000 shares. The stock has declined significantly, trading 54.8% below its 52-week high of $2.72 and down 45.1% over the past 90 days, suggesting a sharp recent sell-off. The company faces material operational headwinds: net income was $-19,177,000.00 over the most recent full fiscal year despite quarterly revenue of $1,533,000.00 and modest annual revenue growth of +8.8%. An insider equity purchase by a CFO during a steep drawdown in an unprofitable company creates a data point for investor attention regarding management's assessment of current valuation, though the motivations behind discretionary insider transactions cannot be definitively inferred from price action and fundamentals alone.

Director Fernandes Prabhavathi buys 10,000 shares of OCGN at $0.91; stock at $0.94, -52.5% from 52-week high.

Director Fernandes Prabhavathi established an initial position of 10,000 shares at $0.91, representing a personal first investment in OCGN stock. The transaction occurred within a steep drawdown context: the stock trades at $0.94, down 52.5% from its 52-week high of $1.98, and has declined 22.3% over the prior 90 days. Ocugen is unprofitable on a full-year basis (net income $-13.0M most recently) but shows strong revenue growth of +142.6% year-over-year, suggesting meaningful business expansion despite ongoing losses. The modest transaction size and absence of prior holdings suggest this is a new director stake rather than a position accumulation by an existing shareholder.

Director Castillo Kirsten purchases 25,000 shares of OCGN at $0.91; holdings increase 50.0% from 50,000 to 75,000 shares

Castillo Kirsten, a director, acquired 25,000 shares at $0.91, expanding her shareholding by 50.0% from 50,000 to 75,000 shares and committing $22.8K to the position. The purchase occurs while OCGN trades -54.0% from its 52-week high of $1.98 and has declined -29.5% over the past 90 days, suggesting the acquisition took place during a period of significant price pressure. The company is currently unprofitable (net income of $-13.0M over its most recent full fiscal year) and posted minimal revenue of $1.1M in the latest quarter, though annual revenue growth of +142.6% year-over-year indicates material business expansion. This substantial directional increase in holdings by a board member warrants tracking alongside the company's path to profitability and near-term operational performance.